Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Benjamin Douglass Hoehn,
Benjamin Douglass Hoehn,
Interim Codman Global Clinical Head, Neurosurgery
Oklahoma Center for Neuroscience
USA
Biography

Professional Experience: Codman Franchise Medical Leader, Johnson and Johnson Medical, Raynham MA, USA 2015-present Duties and responsibilities: o Responsible for Medical Affairs, front-end innovation, NBD, and life cycle management for Codman Global Business. A $700mil business with in JnJ medical Device sector o Hold a position on the Medical Affairs Leadership Team with in JNJ Medical Device Medical affairs COE as well as a member of the Codman Management Board of directors o Key responsibility included identifying and driving innovation in support of the new product development process for the Codman global business, through application of deep clinical, surgical and research expertise while working closely across and with clinical, R&D, regulatory and commercial functions and partners Interim Codman Global Clinical Head, Johnson and Johnson Medical, Raynham MA, USA 2016-2017 Duties and responsibilities: o Responsible for Codman Global Clinical Strategy and Clinical operation o Worked closely with regulatory and clinical partners to design, submit, 510k, HDE, IDE, PMA, PCMF studies to FDA, EU, Japanese regulatory bodies as well as execution in related markets o Managed EU, Japan, Chinese, and US clinical study teams involved in all clinical studies for neurosurgical and neurovascular portfolios INSTITUTION AND LOCATION DEGREE YEAR FIELD OF STUDY Pomona College, Claremont, CA BA 1997 Neuroscience Stanford University, Stanford, CA PhD 2005 Neuroscience Stanford University, Stanford, CA MD 2008 Medicine o Meet with FDA on a regular basis to support submissions and advocate for industry around medical device regulations o Establish a strong working relationship with Carlos Pena, Branch Chief of Neurological Disease sector at FDA to speed application approval process o Worked closely with global KOLs to ensure enrolment progression and protocol adherence was maintained in all operating company study’s o Partnered with Health Economics teams to develop and integrate evidence strategy into clinical studies design. Often in a market specific manner to support reimbursement in that country North Asia Medical Affairs, Clinical, and Safety Director, Johnson and Johnson Medical, Seoul South Korea 2014-2016 Duties and responsibilities: o Responsible for all medical affairs, clinical operations, and safety in North Asia (Korea, Hong Kong, and Taiwan) directed the operational function of the medical affairs, clinical and safety organization in North Asia to achieve organizational as well as regional goals and objectives o Responsible for the design, development and implementation of programs related to educational, promotional and reporting materials across all the Medical Device sectors (Global surgery, orthopedics, Diabetes, Vision care, Wound care) portfolios and products related to early and late phase trials, solicited and non-solicited studies, medical information and publications o Interfaced with key members of the business and Research & Development organizations to drive clinical strategy and contribute to success across Global surgery and Global orthopedics portfolios o Worked closely with business teams to provide medical and scientific support for all product portfolios and support KOL interactions o Worked to ensure the highest levels of product safety vigilance was maintained across all product lines and clinical studies to ensuring patients safety o Partnered with KFDA to improve regulatory and safety systems for the Korean medical device industry o Worked closely head of Hong Health and safety, David Chen, to improve product surveillance by building collaborations with local KOL and hospitals. As well as initiated a training program for new product release to improve user competence and patient safety o Partnered with Asia pacific Innovation teams to identify new technologies by working with regional KOLs or directly with small and large companies. These efforts mainly focused on Korea, Japan and China o Held a position on the North Asia leadership team and Board of Directors, playing a key role in strategy development by providing deep clinical and medical insight as well as perspective, to shape NA/AP business strategy o The position reported into both the Area Sr VP for North Asia and Asia Pacific, the global Medical Affairs COE and had and a cross functional relationship with the Regional Senior Safety Officer for Medical Safety AP, on safety-related issues.

Research Interest

Neuroscience, Basic and Clinical science.

Allied Academies Global Conference Directory

Mail us at

Program Director
neurosciencecongress@alliedmeetings.com
Program Manager
neurosciencecongress@alliedconferences.org
For Conference Queries
neurosciencecongress2018@gmail.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

Insurance

No insurance, of any kind, is included along with the registration in any of the events of the organization.

Transportation

Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

Press/Media

Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization and this conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact http://neurosciencecongress.alliedacademies.com  to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant. 

Cancellation Policy

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

If, due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

Postponement of event

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.


Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to finance@alliedacademies.com. Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

  • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

Copyright © 2018-2019 Allied Academies, All Rights Reserved.